Robot-assisted surgery for lung cancer: State of the art and perspectives

Veronesi, Giulia; Novellis, Pierluigi; Voulaz, Emanuele; Alloisio, Marco

doi:10.1016/j.lungcan.2016.09.004

Cited by 102 publications

(79 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The rate of complete resection in the present study (97.4%) is also consistent with data in the literature. (13,17) Few studies have drawn direct comparisons between video-assisted thoracoscopic surgery and robotic surgery. However, there is evidence that robotic surgery is superior to traditional video-assisted thoracoscopic surgery.…”

Section: Discussionmentioning

confidence: 99%

Robotic thoracic surgery for non-small cell lung cancer: initial experience in Brazil

et al. 2020

View full text Add to dashboard Cite

Objective: To describe the morbidity, mortality, and rate of complete resection associated with robotic surgery for the treatment of non-small cell lung cancer in Brazil, as well as to report the rates of overall survival and disease-free survival in patients so treated. Methods: This was a retrospective study of patients diagnosed with non-small cell lung carcinoma and undergoing resection by robotic surgery at one of six hospitals in Brazil between February of 2015 and July of 2018. Data were collected retrospectively from the electronic medical records. Results: A total of 154 patients were included. The mean age was 65 ± 9.5 years (range, 30-85 years). The main histological diagnosis was adenocarcinoma, which was identified in 128 patients (81.5%), followed by epidermoid carcinoma, identified in 14 (9.0%). Lobectomy was performed in 133 patients (86.3%), and segmentectomy was performed in 21 (13.7%). The mean operative time was 209 ± 80 min. Postoperative complications occurred in 32 patients (20.4%). The main complication was air leak, which occurred in 15 patients (9.5%). The median (interquartile range) values for hospital stay and drainage time were 4 days (3-6 days) and 2 days (2-4 days), respectively. There was one death in the immediate postoperative period (30-day mortality rate, 0.5%). The mean follow-up period was 326 ± 274 days (range, 3-1,110 days). Complete resection was achieved in 97.4% of the cases. Overall mortality was 1.5% (3 deaths), and overall survival was 97.5%. Conclusions: Robotic pulmonary resection proved to be a safe treatment for lung cancer. Longer follow-up periods are required in order to assess long-term survival.

show abstract

Section: Discussionmentioning

confidence: 99%

Robotic thoracic surgery for non-small cell lung cancer: initial experience in Brazil

et al. 2020

View full text Add to dashboard Cite

show abstract

“…100 To date, no randomized trials have reported the comparative data between RATS and VATS/thoracotomy for lung cancer. 101 The extent of parenchymal resection remains an area of evolution. There are several situations where sublobar resection should be considered as primary treatment for early-stage NSCLC.…”

Section: Tnm Staging Systemmentioning

confidence: 99%

Scientific Advances in Thoracic Oncology 2016

Soo

Cummings

Jett

et al. 2017

Journal of Thoracic Oncology

View full text Add to dashboard Cite

Lung cancer care is rapidly changing with advances in genomic testing, the development of next-generation targeted kinase inhibitors, and the continued broad study of immunotherapy in new settings and potential combinations. The International Association for the Study of Lung Cancer and the Journal of Thoracic Oncology publish this annual update to help readers keep pace with these important developments. Experts in thoracic cancer and care provide focused updates across multiple areas, including prevention and early detection, molecular diagnostics, pathology and staging, surgery, adjuvant therapy, radiotherapy, molecular targeted therapy, and immunotherapy for NSCLC, SCLC, and mesothelioma. Quality and value of care and perspectives on the future of lung cancer research and treatment have also been included in this concise review.

show abstract

“…In our opinion the presence of a utility incision is related to some advantages as the possibility of palpating the lung and removing the specimen from the same incision; in case of vascular bleeding it allows a rapid conversion, with the possibility of enlarging the same incision; it also offers a comfortable access of a sponge in the case of small bleeding and avoids one trocar incision compared to the complete portal technique CO 2 is not routinely used in this techniques, but it is indicated in selected cases such as obesity, relaxation of the diaphragm, incomplete lung exclusion due to air trapping in COPD patients or problems with the tracheal tube (13).…”

Section: State Of the Art Of Robotic Lung Lobectomy Techniquesmentioning

confidence: 99%